|
ZNF844 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.43699996136127E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85570000477142E-08 |
| Normal-vs-Stage2 |
2.71870000001506E-06 |
| Normal-vs-Stage3 |
7.20350001870429E-10 |
| Normal-vs-Stage4 |
5.71000025040291E-10 |
| Stage1-vs-Stage2 |
4.300200E-01 |
| Stage1-vs-Stage3 |
6.837700E-02 |
| Stage1-vs-Stage4 |
4.804300E-02 |
| Stage2-vs-Stage3 |
4.482000E-02 |
| Stage2-vs-Stage4 |
3.922500E-02 |
| Stage3-vs-Stage4 |
7.091800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.81260004175721E-09 |
| Normal-vs-AfricanAmerican |
1.65944999999112E-05 |
| Normal-vs-Asian |
2.26580000317611E-08 |
| Caucasian-vs-AfricanAmerican |
4.794600E-01 |
| Caucasian-vs-Asian |
9.240000E-01 |
| AfricanAmerican-vs-Asian |
4.815800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.22599996610751E-09 |
| Normal-vs-Female |
7.97279997577505E-09 |
| Male-vs-Female |
6.090000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.91910000008266E-08 |
| Normal-vs-Age(41-60Yrs) |
4.73460004535298E-09 |
| Normal-vs-Age(61-80Yrs) |
7.73620001393027E-09 |
| Normal-vs-Age(81-100Yrs) |
3.658100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.685600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.205000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.695600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.469200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.161600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.352200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.817400E-03 |
| Classical-VS-Follicular |
4.649000E-01 |
| Classical-VS-Other |
4.682600E-01 |
| Classical-VS-Normal |
2.54119999487656E-08 |
| Tall-VS-Follicular |
4.221000E-03 |
| Tall-VS-Other |
6.579000E-01 |
| Tall-VS-Normal |
1.48529966104149E-10 |
| Follicular-VS-Other |
3.720200E-01 |
| Follicular-VS-Normal |
4.0950000002038E-07 |
| Other-VS-Normal |
5.776100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.57399999700658E-08 |
| Normal-vs-N1 |
1.39010025712594E-10 |
| N0-vs-N1 |
2.236200E-02 |
|
|
